ConductScience.org, home

Paper20162413

Unbalanced reporting of benefits and harms in abstracts on rofecoxib.

Jørgensen AW and 2 others. Eur J Clin Pharmacol, 2010. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Unbalanced reporting of benefits and harms in abstracts on rofecoxib. Papers, record 20162413. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20162413

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Unbalanced reporting of benefits and harms in abstracts on rofecoxib.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.07
iCite
Revised in PubMed
2021-10-20
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jørgensen AWAnders W
2Jørgensen KJKarsten Juhl
3Gøtzsche PCPeter C

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Inflammatory Agents, Non-SteroidalMajor topic
Gastrointestinal HemorrhageMajor topic
LactonesMajor topic
SulfonesMajor topic
ThrombosisMajor topic
Clinical Trials as Topic
Double-Blind Method
Humans

Source PubMed

Download CSV of topics

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12702836Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis.Control Clin Trials1989https://conductscience.org/library/papers/2702836PubMed
218221781CONSORT for reporting randomised trials in journal and conference abstracts.Lancet2008https://conductscience.org/library/papers/18221781PubMed
317569906FDA places "black box" warning on antidiabetes drugs.BMJ2007https://conductscience.org/library/papers/17569906PubMed
411509060Risk of cardiovascular events associated with selective COX-2 inhibitors.JAMA2001https://conductscience.org/library/papers/11509060PubMed
512775615Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.BMJ2003https://conductscience.org/library/papers/12775615PubMed
68707496Influences on the quality of published drug studies.Int J Technol Assess Health Care1996https://conductscience.org/library/papers/8707496PubMed
715917385Academic medical centers' standards for clinical-trial agreements with industry.N Engl J Med2005https://conductscience.org/library/papers/15917385PubMed
819273522Research Transparency. Industry attack on academics.BMJ2009https://conductscience.org/library/papers/19273522PubMed
912672188Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis.J Rheumatol2003https://conductscience.org/library/papers/12672188PubMed
1017227134Ghost authorship in industry-initiated randomised trials.PLoS Med2007https://conductscience.org/library/papers/17227134PubMed
1111712924Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.JAMA2001https://conductscience.org/library/papers/11712924PubMed
129874808Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/9874808PubMed
1311792343Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone).Am J Cardiol2002https://conductscience.org/library/papers/11792343PubMed
1417124012Dangerous deception--hiding the evidence of adverse drug effects.N Engl J Med2006https://conductscience.org/library/papers/17124012PubMed
1517235089What have we learnt from Vioxx?BMJ2007https://conductscience.org/library/papers/17235089PubMed
1610514410Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions.Am J Pathol1999https://conductscience.org/library/papers/10514410PubMed
1716339408Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8.N Engl J Med2005https://conductscience.org/library/papers/16339408PubMed
187715044The accuracy of drug information from pharmaceutical sales representatives.JAMA1995https://conductscience.org/library/papers/7715044PubMed
1915625342Rofecoxib, Merck, and the FDA.N Engl J Med2004https://conductscience.org/library/papers/15625342PubMed
2018413874Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.JAMA2008https://conductscience.org/library/papers/18413874PubMed

See all 47 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
42852177Understanding pharmaceutical industry coalitions: a case study of Mallinckrodt.Humanit Soc Sci Commun2026https://conductscience.org/library/papers/42852177

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20162413

GET https://conductscience.org/api/papers/v1/20162413/references?page=2